Welcome to our dedicated page for Delivra Health news (Ticker: DHBUF), a resource for investors and traders seeking the latest updates and insights on Delivra Health stock.
Delivra Health (DHBUF) delivers science-backed wellness solutions through brands like Dream Water and LivRelief, addressing modern health challenges from sleep support to pain management. This dedicated news hub provides investors and industry observers with essential updates on the company’s progress in the competitive health CPG sector.
Track earnings reports, product innovations, and strategic partnerships through verified press releases and curated analysis. Our repository ensures timely access to material developments affecting DHBUF’s market position, including regulatory milestones and distribution network expansions.
Discover updates on the company’s natural formulations, retail distribution growth, and e-commerce initiatives. Content is organized for quick scanning while maintaining depth for professional analysis. Bookmark this page to monitor DHBUF’s evolving role in advancing accessible alternative wellness solutions across North America.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), a leader in consumer packaged goods in the health and wellness sector, has announced its upcoming annual financial results report for the year ending June 30, 2024. The company will host a conference call on Tuesday, October 8, 2024, at 11:00 a.m. (EST) / 8:00 a.m. (PST) to discuss these results.
The conference call will feature Gord Davey, President and CEO, and Jack Tasse, CFO, who will conduct a Q&A session following management's prepared remarks. Interested parties can join the call by dialing 1-844-763-8274 (Canada/USA Toll Free) or +1-647-484-8814 (International Toll). Participants are advised to dial in 10 minutes before the scheduled start time.
A replay of the call will be available on the company's investor page by the end of the business day on October 8, 2024.
Delivra Health Brands (TSXV: DHB, OTCQB: DHBUF), a leader in the health and wellness sector, has announced the grant of 14,000,000 incentive stock options. This resolution, passed by the Board on May 28, 2024, allows directors, officers, and employees to purchase shares at $0.05 each. These options vest annually over three years and have a five-year term. The initiative aims to align the interests of the company's insiders with its long-term performance and growth strategies.
Delivra Health Brands reported a 36% YoY revenue growth, achieving $8,792K in net revenue for the nine months ending March 31, 2024. The quarterly revenue rose by 31% to $3,071K. The company's adjusted EBITDA improved to $845K from $9K YoY. Gross profit for the nine months was $4,566K, a 61% increase, with a gross margin of 52%, up from 44%. However, total expenses increased by 22% to $3,973K due to marketing initiatives. Quarterly gross profit was $1,540K with a 50% margin. Net loss was $702K for the nine months, compared to $178K last year. The loss per share stood at $0.003 basic and $0.002 diluted. Overall, Delivra Health shows strong revenue growth and improved profitability, despite higher expenses.
FAQ
What is the current stock price of Delivra Health (DHBUF)?
What is the market cap of Delivra Health (DHBUF)?
